Press Release |
San Francisco at Leading Edge of Global Neurotechnology Industry, Says New Report
* Reuters is not responsible for the content in this press release.
SAN FRANCISCO--(Business Wire)-- According to a new study conducted by NeuroInsights and sponsored by the Neurotechnology Industry Organization (NIO), the San Francisco Bay Area leads the world in neurotechnology - drugs, medical devices, biologics, cell-based therapeutics, and diagnostics for the treatment of brain and nervous system illnesses such as Alzheimer`s disease, depression, obesity, stroke, epilepsy and chronic pain. The San Francisco Bay Area beat out other technology centers including Boston, New York/New Jersey, Greater London, San Diego and Los Angeles/Irvine, according to the study, "Neurotech Clusters 2010: Mapping the Business of Neuroscience." The rankings are based on three broad factors: number of neuroscience-focused companies, availability of local risk capital and social infrastructure (universities, hospitals, research institutes). The San Francisco Bay Area ranked first in number of companies and risk capital, while Boston ranked first in social infrastructure. "This report confirms that San Francisco is on the global forefront of neurotechnology," said San Francisco Mayor Gavin Newsom. "The strength and concentration of San Francisco neurotech businesses is further evidence that the City is on the leading edge of groundbreaking research to improve human health." "The City of San Francisco resides at the nexus of the world's leading neurotechnology cluster," says Zack Lynch, Executive Director of the Neurotechnology Industry Organization. "With the continued growth of the Mission Bay complex the city is poised to extend its leadership in supporting organizations who are focused on developing treatments and cures for the nearly 2 billion people worldwide who suffer from neurological disease and mental illness." Among the ninety-four companies involved in neuroscience in the San Francisco Bay Area, San Francisco is home to thirteen neurotech companies including Adynxx, BrainsOnline, Carmot Therapeutics, Emotiv Systems, Eos Neuroscience, Lumos Labs, Medivation, Merck Research Laboratories, Neurox Pharmaceuticals, Photoswitch Biosciences, Posit Science, Simprota, Synarc, and Xalud Therapeutics as well as being the headquarters of the Neurotechnology Industry Organization. Further supporting San Francisco`s leadership are top tier academic research centers including UCSF`s W.M. Keck Foundation Center for Integrative Neuroscience, Sloan-Swartz Center for Theoretical Neurobiology, Conte Center for Neuroscience Research, Wheeler Center for the Neurobiology of Addiction, and the Gladstone Institute of Neurological Disease. University of California, San Francisco Medical Center was ranked 18th for psychiatry, 10th for ophthalmology, 4th for neurology and neurosurgery. NIO Zack Lynch Executive Director 415-341-0193 (Press) firstname.lastname@example.org or San Francisco Mayor's Office of Communications Joe Arellano Chief Deputy Communications Director/Sub-Director de Prensa Main: 415-554-6131 (Press) Joe.Arellano@sfgov.org Copyright Business Wire 2009